271 related articles for article (PubMed ID: 21915801)
61. Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.
Tongu M; Harashima N; Monma H; Inao T; Yamada T; Kawauchi H; Harada M
Cancer Immunol Immunother; 2013 Feb; 62(2):383-91. PubMed ID: 22926062
[TBL] [Abstract][Full Text] [Related]
62. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
63. Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.
Heylmann D; Bauer M; Becker H; van Gool S; Bacher N; Steinbrink K; Kaina B
PLoS One; 2013; 8(12):e83384. PubMed ID: 24376696
[TBL] [Abstract][Full Text] [Related]
64. Human Endothelial Cells Modulate CD4
Lim WC; Olding M; Healy E; Millar TM
Front Immunol; 2018; 9():565. PubMed ID: 29628925
[TBL] [Abstract][Full Text] [Related]
65. Adoptive immunotherapy with transient anti-CD4 treatment enhances anti-tumor response by increasing IL-18Rα
Kim SH; Cho E; Kim YI; Han C; Choi BK; Kwon BS
Nat Commun; 2021 Sep; 12(1):5314. PubMed ID: 34493727
[TBL] [Abstract][Full Text] [Related]
66. PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients.
Sun S; Fei X; Mao Y; Wang X; Garfield DH; Huang O; Wang J; Yuan F; Sun L; Yu Q; Jin X; Wang J; Shen K
Cancer Immunol Immunother; 2014 Apr; 63(4):395-406. PubMed ID: 24514954
[TBL] [Abstract][Full Text] [Related]
67. Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches.
Horn T; Grab J; Schusdziarra J; Schmid S; Maurer T; Nawroth R; Wolf P; Pritsch M; Gschwend JE; Kübler HR; Beckhove P
Int J Cancer; 2013 Nov; 133(9):2145-56. PubMed ID: 23625723
[TBL] [Abstract][Full Text] [Related]
68. ICOS-ligand expression on plasmacytoid dendritic cells supports breast cancer progression by promoting the accumulation of immunosuppressive CD4+ T cells.
Faget J; Bendriss-Vermare N; Gobert M; Durand I; Olive D; Biota C; Bachelot T; Treilleux I; Goddard-Leon S; Lavergne E; Chabaud S; Blay JY; Caux C; Ménétrier-Caux C
Cancer Res; 2012 Dec; 72(23):6130-41. PubMed ID: 23026134
[TBL] [Abstract][Full Text] [Related]
69. The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial.
Huijts CM; Lougheed SM; Bodalal Z; van Herpen CM; Hamberg P; Tascilar M; Haanen JB; Verheul HM; de Gruijl TD; van der Vliet HJ;
Cancer Immunol Immunother; 2019 Mar; 68(3):503-515. PubMed ID: 30652208
[TBL] [Abstract][Full Text] [Related]
70. Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.
Slingluff CL; Petroni GR; Chianese-Bullock KA; Smolkin ME; Ross MI; Haas NB; von Mehren M; Grosh WW
J Clin Oncol; 2011 Jul; 29(21):2924-32. PubMed ID: 21690475
[TBL] [Abstract][Full Text] [Related]
71. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
[TBL] [Abstract][Full Text] [Related]
72. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.
Olino K; Wada S; Edil BH; Pan X; Meckel K; Weber W; Slansky J; Tamada K; Lauer P; Brockstedt D; Pardoll D; Schulick R; Yoshimura K
Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S597-607. PubMed ID: 21979110
[TBL] [Abstract][Full Text] [Related]
73. Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.
Zhang HH; Mei MH; Fei R; Liao WJ; Wang XY; Qin LL; Wang JH; Wei L; Chen HS
Int J Oncol; 2010 Apr; 36(4):841-8. PubMed ID: 20198327
[TBL] [Abstract][Full Text] [Related]
74. Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer.
Li CH; Kuo WH; Chang WC; Huang SC; Chang KJ; Sheu BC
Immunol Res; 2011 Oct; 51(1):71-9. PubMed ID: 21918886
[TBL] [Abstract][Full Text] [Related]
75. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.
Liyanage UK; Moore TT; Joo HG; Tanaka Y; Herrmann V; Doherty G; Drebin JA; Strasberg SM; Eberlein TJ; Goedegebuure PS; Linehan DC
J Immunol; 2002 Sep; 169(5):2756-61. PubMed ID: 12193750
[TBL] [Abstract][Full Text] [Related]
76. Phase I lead-in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour-bearing dogs.
Rasmussen RM; Kurzman ID; Biller BJ; Guth A; Vail DM
Vet Comp Oncol; 2017 Jun; 15(2):421-430. PubMed ID: 26522053
[TBL] [Abstract][Full Text] [Related]
77. Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function.
Su Y; Huang X; Wang S; Min WP; Yin Z; Jevnikar AM; Zhang ZX
Eur J Immunol; 2012 May; 42(5):1216-25. PubMed ID: 22539294
[TBL] [Abstract][Full Text] [Related]
78. Interleukin 2 and interleukin 10 function synergistically to promote CD8
Li X; Lu P; Li B; Zhang W; Yang R; Chu Y; Luo K
Int J Biochem Cell Biol; 2017 Jun; 87():1-7. PubMed ID: 28274688
[TBL] [Abstract][Full Text] [Related]
79. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.
Beauford SS; Kumari A; Garnett-Benson C
BMC Immunol; 2020 Apr; 21(1):18. PubMed ID: 32299365
[TBL] [Abstract][Full Text] [Related]
80. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer.
Severson JJ; Serracino HS; Mateescu V; Raeburn CD; McIntyre RC; Sams SB; Haugen BR; French JD
Cancer Immunol Res; 2015 Jun; 3(6):620-30. PubMed ID: 25701326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
